BAP Stock Analysis: Credicorp | NYSE
Banks - Regional | NYSE, USA | Market Cap: 29.021m USD | 12M Return: 41.1% | BMG2519Y1084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 129M
EPS Trend: 98.4%
Qual. Beats: 0
Rev. Trend: 87.4%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Credicorp Ltd. (NYSE: BAP) is a Lima, Peru-based financial holding company founded in 1889 that operates across Latin America and select international markets, including Bermuda, the Cayman Islands, and the United States. The company runs four business segments: Universal Banking, Insurance/Medical Services/Pensions, Microfinance, and Investment Management and Advisory, making it one of the most diversified financial groups in the Andean region.
Its Universal Banking segment handles corporate and retail lending, deposits, and current accounts, while the Insurance and Pensions unit covers commercial property, transport, marine, auto, life, and health policies, alongside private pension fund administration. The Microfinance segment targets small and microenterprises, a notable growth area in emerging markets where access to formal credit remains limited. The Investment Management and Advisory arm offers brokerage, asset management, capital markets structuring, securitization, custody, trustee, and payment processing services, and also operates a digital e-commerce platform.
As a large-cap stock classified under the Diversified Banks sub-industry, Credicorp combines traditional commercial banking with insurance, pensions, and asset management under one corporate umbrella - a structure common among full-service financial conglomerates in Latin America, where cross-selling across banking, insurance, and pension products is a key driver of profitability.
- Peru economic growth drives loan demand and NIM expansion
- Microfinance segment outpaces traditional banking amid rising informal sector lending
- Insurance and pension fees grow on Peru regulatory tailwinds and AUM expansion
| Net Income: 7.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.92 > 1.0 |
| NWC/Revenue: -329.5% < 20% (prev -360.0%; Δ 30.51% < -1%) |
| CFO/TA 0.03 > 3% & CFO 8.05b > Net Income 7.53b |
| Net Debt (-48.1b) to EBITDA (11.8b): -4.06 < 3 |
| Current Ratio: 0.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.4m) vs 12m ago -0.07% < -2% |
| Gross Margin: 75.79% > 18% (prev 60.66%; Δ 15.13% > 0.5%) |
| Asset Turnover: 12.02% > 50% (prev 9.62%; Δ 2.40% > 0%) |
| Interest Coverage Ratio: 2.00 > 6 (EBIT TTM 10.9b / Interest Expense TTM 5.44b) |
| A: -0.37 (Total Current Assets 83.2b - Total Current Liabilities 191b) / Total Assets 287b |
| B: 0.02 (Retained Earnings 6.01b / Total Assets 287b) |
| C: 0.04 (EBIT TTM 10.9b / Avg Total Assets 271b) |
| D: 0.16 (Book Value of Equity 39.6b / Total Liabilities 246b) |
| Altman-Z'' = -1.95 = D |
As of November 20, 2026, the stock is trading at USD 342.75 with a total of 496,762 shares traded. Over the past week, the price has changed by -6.20%, over one month by -10.73%, over three months by -7.11% and over the past year by +41.06%.
Current recommended Stop Loss: 326.60 (which is 4.7% or 1.3 ATR below the current price).
Credicorp has received a consensus analysts rating of 4.43. Therefore, it is recommended to buy BAP.
- StrongBuy: 8
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 435.8 | 27.1% |
Market Cap PEN = 99.1b (29.0b USD * 3.4144 USD.PEN)
P/E Trailing = 13.2587
P/E Forward = 10.0908
P/S = 1.2625
P/B = 2.6203
P/EG = 4.5503
Revenue TTM = 32.6b PEN
EBIT TTM = 10.9b PEN
EBITDA TTM = 11.8b PEN
Long Term Debt = 24.5b PEN (from longTermDebt, last quarter)
Short Term Debt = 8.08b PEN (from shortTermDebt, last quarter)
Debt = 33.2b PEN (from shortLongTermDebtTotal, last quarter) + Leases 612.3m
Net Debt = -48.1b PEN (calculated: Debt 33.2b - CCE 81.3b)
Enterprise Value = 51.0b PEN (99.1b + Debt 33.2b - CCE 81.3b)
Interest Coverage Ratio = 2.00 (Ebit TTM 10.9b / Interest Expense TTM 5.44b)
EV/FCF = 6.59x (Enterprise Value 51.0b / FCF TTM 7.74b)
FCF Yield = 15.17% (FCF TTM 7.74b / Enterprise Value 51.0b)
FCF Margin = 23.75% (FCF TTM 7.74b / Revenue TTM 32.6b)
Net Margin = 23.13% (Net Income TTM 7.53b / Revenue TTM 32.6b)
Gross Margin = 75.79% ((Revenue TTM 32.6b - Cost of Revenue TTM 7.88b) / Revenue TTM)
Gross Margin QoQ = 73.80% (prev 74.92%)
Tobins Q-Ratio = 0.18 (Enterprise Value 51.0b / Total Assets 287b)
Interest Expense / Debt = 16.37% (Interest Expense 5.44b / Debt 33.2b)
Taxrate = 29.17% (3.17b / 10.9b)
NOPAT = 7.70b (EBIT 10.9b * (1 - 29.17%))
Current Ratio = 0.44 (Total Current Assets 83.2b / Total Current Liabilities 191b)
Debt / Equity = 0.84 (Debt 33.2b / totalStockholderEquity, last quarter 39.6b)
Debt / EBITDA = -4.06 (Net Debt -48.1b / EBITDA 11.8b)
Debt / FCF = -6.22 (Net Debt -48.1b / FCF TTM 7.74b)
Total Stockholder Equity = 38.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.78% (Net Income 7.53b / Total Assets 287b)
RoE = 19.68% (Net Income TTM 7.53b / Total Stockholder Equity 38.3b)
RoCE = 17.31% (EBIT 10.9b / Capital Employed (Equity 38.3b + L.T.Debt 24.5b))
RoIC = 7.51% (NOPAT 7.70b / Invested Capital 103b)
WACC = 8.62% (E(99.1b)/V(132b) * Re(7.62%) + D(33.2b)/V(132b) * Rd(16.37%) * (1-Tc(0.29)))
Discount Rate = 7.62% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 4.71 | Cagr: 0.05%
[DCF] Terminal Value 77.11% ; FCFF base≈6.46b ; Y1≈7.41b ; Y5≈10.9b
[DCF] Fair Price = 2.58k (EV 157b - Net Debt -48.1b = Equity 205b / Shares 79.4m; r=8.62% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.45 | EPS CAGR: 25.29% | SUE: -0.72 | # QB: 0
Revenue Correlation: 87.40 | Revenue CAGR: 9.37% | SUE: 0.85 | # QB: 1
EPS current Quarter (2027-03-31): EPS=7.83 | Chg30d=-0.81% | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=29.05 | Chg30d=-2.31% | Revisions=+29% | GrowthEPS=+12.3% | GrowthRev=+11.8%
EPS next Year (2027-12-31): EPS=34.20 | Chg30d=-0.13% | Revisions=+12% | GrowthEPS=+17.8% | GrowthRev=+11.4%
[Analyst] Revisions Ratio: +21% (up=7, down=4)